KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,366,548 | -28.4% | 1,285,508 | -8.2% | 0.04% | -24.1% |
| Q2 2023 | $303,641,393 | +4.0% | 1,400,237 | -12.9% | 0.06% | 0.0% |
| Q1 2023 | $291,868,960 | +40.8% | 1,606,854 | +52.3% | 0.06% | +38.1% |
| Q4 2022 | $207,322,436 | -7.9% | 1,055,076 | +5.4% | 0.04% | -12.5% |
| Q3 2022 | $225,178,000 | +89.7% | 1,001,103 | +6.7% | 0.05% | +100.0% |
| Q2 2022 | $118,685,000 | +9.7% | 938,149 | +9.9% | 0.02% | +26.3% |
| Q1 2022 | $108,194,000 | -17.0% | 853,337 | -14.2% | 0.02% | -9.5% |
| Q4 2021 | $130,285,000 | +6.3% | 994,539 | -0.7% | 0.02% | 0.0% |
| Q3 2021 | $122,560,000 | +13.6% | 1,001,886 | +5.8% | 0.02% | +16.7% |
| Q2 2021 | $107,900,000 | +36.6% | 946,581 | +44.1% | 0.02% | +28.6% |
| Q1 2021 | $78,979,000 | +484.4% | 656,896 | +393.8% | 0.01% | +600.0% |
| Q4 2020 | $13,515,000 | +2309.1% | 133,031 | +374.6% | 0.00% | – |
| Q2 2019 | $561,000 | – | 28,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |